Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs

Today, 4:55 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)

ABEO

6 minute read

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data

By Shanthi Rexaline

Today, 4:55 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)

ABSI

1 minute read

10 Biggest Price Target Changes For Friday

By Lisa Levin

Today, 4:55 PM

UBS cut FedEx Corporation (NYSE: FDX) price target from $397 to $380. FedEx shares fell 0.2% to $258.00 in pre-market trading.

ACCD

5 minute read

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera’s COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

By Shanthi Rexaline

Today, 4:55 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)

ABCL

1 minute read

Keybanc Maintains Overweight on Repligen, Raises Price Target to $335

By Benzinga Newsdesk

Today, 4:55 PM

Keybanc analyst Paul Knight maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $255 to $335.

RGEN

1 minute read

Repligen Reinforces Proteins Business With $150M Avitide Acquisition Deal

By Vandana Singh

Today, 4:55 PM

Repligen Corporation (NASDAQ:RGEN) has agreed to acquire privately-held Avitide Inc for approximately $150 million in cash and stock.…

RGEN

5 minute read

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study

By Shanthi Rexaline

Today, 4:55 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15)

ACHL

2 minute read

Repligen To Acquire Avitide For $150M

By Bill Haddad

Today, 4:55 PM

Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a definitive agreement to acquire privately-held Avitide Inc., for approximately $150 million, comprised of $75 million in cash plus $75 million in Repligen common stock in addit

RGEN

2 minute read

Chief Executive Officer Of Repligen Trades $8.18 Million In Company Stock

By Benzinga Insights

Today, 4:55 PM

Anthony Hunt, Chief Executive Officer at Repligen (NASDAQ:RGEN), made a large buy and sell of company shares on September 9, according to a new SEC filing.

RGEN

2 minute read

News

Repligen And Navigo GmbH Announce Launch Of Industry-First Protein A Ligand for Purification Of pH Sensitive Antibodies

By Benzinga Newsdesk

Today, 4:55 PM

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), today announced they have completed development and validation

RGEN